Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.

Thrombopenia Clinical Trial

Official title:

Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00336687
• Other study ID #: CHU63-0013
• Status: Completed
• Phase: N/A
• First received: June 13, 2006
• Last updated: March 26, 2010
• Start date: July 2005
• Est. completion date: November 2006

Study information

• Verified date: March 2010
• Source: University Hospital, Clermont-Ferrand
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Observational

Clinical Trial Summary

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

Description:

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 322
• Est. completion date: November 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Thrombopenia in reanimation

Exclusion Criteria:

• Pregnancy

• Contraindication of myelogram

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Thrombocytopenia
• Thrombocytosis
• Thrombopenia

Locations

Country	Name	City	State
France	Clermont-Ferrand University Hospital	Clermont-Ferrand	Auvergne

Sponsors (4)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand	Centre Hospitalier Universitaire de Saint Etienne, LA ROCHE SUR YON HOSPITAL, Moulins Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Epidemiology of Thrombopenia and its consequences.		in reanimation	Yes
Secondary	The impact of cost and mortality of Thrombopenia in reanimation.		in reanimation	Yes